LOW vs REGN · P/E 18, rev $86.29B vs P/E 14, rev $14.34B
Lowe's Companies Inc (LOW) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LOW and REGN stock pages for the full models.
Not investment advice.